Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLTG.L Regulatory News (BLTG)

  • There is currently no data for BLTG

Business Update

31 May 2011 07:00

RNS Number : 4905H
Regenersis PLC
31 May 2011
 



 

31 May 2011

 

Regenersis plc

 

("Regenersis" or the "Group")

 

Business Update

 

 

Regenersis, a strategic outsourcing partner to many of the world's leading consumer technology companies, is pleased to provide an update on progress. It is anticipated that the outcome of the ongoing operational and strategic review, which commenced in March, will be shared with investors before the end of this financial year in June. Today, the Group is able to announce several specific actions and changes.

 

Organisation Changes

 

Our recent activity as a Group has been designed to ensure that our efforts focus on markets where we are able to differentiate our services, create competitive barriers and deliver sustainable growth in revenues and margins. We are moving rapidly to implement a new organisation structure which supports this intent, including a global sales force and new reporting and incentive structures, and we have made several key senior appointments in recent months.

 

Ian Powell has joined the Group as Group Managing Director reporting to the Executive Chairman. Ian has a long and successful track record in driving significant operational and profit improvement in complex, multi-geography businesses. Most recently he delivered a step change in profitability as CEO of Chapelthorpe Plc, a fibres manufacturing business with factories in the UK, Austria, Russia and the USA. Prior to that he ran the UK operations of 4imprint plc.

 

Sergio Tansini, previously Managing Director of our Mobile division has taken on a new role as Group Sales Director. Winning and expanding large, multi-geography accounts is critical to boosting growth across the Group and Sergio will spearhead this activity, reporting directly to the Executive Chairman.

 

Andrew Lee has been appointed as Managing Director of the UK Mobile businesses. His previous roles include Managing Director of Dataforce Group (marketing and logistics), Group Operations Director of N Brown Group plc (catalogue retailer), and Managing Director of Demand Chain Logistics at the Unipart Group. Andy is currently a non-executive Director of the Group and will step down from this role in order to pick up these executive responsibilities. He will be replaced in due course by a new independent non-executive Director.

 

Head Office Relocation

 

The Board has reduced the size of the Group central team and relocated the Group functions to our existing facility in Huntingdon. Jeremy Wilson the Chief Financial Officer continues in his role, reporting to the Executive Chairman. Central Costs in the next financial year are expected to be around ÂŁ0.9 million lower than the ÂŁ2.7 million in the last reported financial year.

 

Contracts

 

After a protracted period of negotiation stretching back to 2010 the Group has not been successful in renewing its contract with Hutchison 3G UK. The Board anticipates that this effect will not impact expectations for the current financial year and, furthermore, we believe that any impact in the next financial year to June 2012 will be more than outweighed by factors including the contribution of new business recently won or at an advanced stage of negotiation.

 

Banking

 

The Board is pleased to report that it has secured a ÂŁ15m banking facility with HSBC until October 2015, replacing the Group's previous banking arrangements and providing a good platform for growth.

 

 

Matthew Peacock, Executive Chairman of Regenersis commented:

 

"I am encouraged by the early strategic progress we have made since March. We have brought new skills in to the senior team, increasingly focused our efforts on differentiating our services and undertaken further work to fine-tune the Regenersis offer. This work continues and I look forward to presenting a fuller account of our strategic plans in June."

 

 

Enquiries:

 

Regenersis plc

+44 (0) 1865 471 900

Matthew Peacock / Jeremy Wilson

 

 

 

Arden Partners plc

+44 (0) 121 423 8900

Steve Douglas

 

 

 

Financial Dynamics

+44 (0) 20 7831 3113

Matt Dixon / Charles Palmer

 

 

 

 

Ends

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAXSXAFSFEFF
Date   Source Headline
17th Jan 20073:07 pmRNSOffer Update
15th Jan 20073:18 pmRNSRule 8.3- Fonebak plc
11th Jan 200710:44 amRNSResult of EGM
11th Jan 20077:01 amRNSOffer Update
9th Jan 200712:23 pmRNSNotification of Interest
3rd Jan 20075:55 pmRNSNotification of Interest
19th Dec 20067:02 amRNSPosting of Offer Document
18th Dec 20068:25 amRNSTotal Voting Rights
14th Dec 20067:22 amRNSOffer for CRC Group plc
17th Oct 20063:36 pmRNSNotice of AGM
4th Oct 20067:01 amRNSPreliminary Results
19th Sep 20065:13 pmRNSNotice of Results
18th Sep 200610:00 amRNSContract Win
30th Aug 20065:15 pmRNSNotification of Interest
30th Aug 20064:47 pmRNSShareholding in Company
31st Jul 20067:02 amRNSNotification of Interest
27th Jun 20067:00 amRNSTrading Update
22nd Mar 20064:49 pmRNSShareholder Interests
21st Mar 20067:00 amRNSDirector/PDMR Shareholding
13th Mar 20067:02 amRNSInterim Results
24th Feb 20067:01 amRNSNotice of Results
6th Feb 20069:29 amRNSNotification of Shareholders
18th Jan 20067:00 amRNSHolding(s) in Company
17th Jan 20061:05 pmRNSNotification of Interest
12th Jan 20062:06 pmRNSDirector/PDMR Shareholding
18th Nov 20057:00 amRNSHolding(s) in Company
31st Oct 20056:29 pmRNSHolding(s) in Company
28th Oct 20056:27 pmRNSShareholding in Company
28th Oct 20056:25 pmRNSNotice of Interest in Shares
27th Oct 200512:31 pmRNSAGM Statement
26th Sep 20057:00 amRNSFinal Results
8th Sep 20054:33 pmRNSHolding(s) in Company
1st Aug 20057:00 amRNSAcquisition
21st Jul 20057:01 amRNSTrading Statement
21st Apr 20058:48 amRNSQueen's Award
19th Apr 20052:54 pmRNSHolding(s) in Company
15th Apr 20054:38 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.